Short answer
NEOGENOMICS INC (NEO) filed its Q1 2026 10-Q quarterly report on Apr 28, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $187M (up 11.1% year over year) with net income of −$17M.
Q1 2026 key financials · XBRL
- Revenue
- $187M
- +11.1% YoY
- Net income
- −$17M
- +34.0% YoY
- Operating margin
- -9.8%
- Gross margin
- 43.3%
Source: XBRL data from the NEOGENOMICS INC (NEO) Q1 2026 10-Q on SEC EDGAR. USD.
NEOGENOMICS INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Section 'mda' was empty or not found.
Risk Factors
- No material changes to risk factors identified in the fiscal 2026 10-Q
- Carried-forward risks remain those disclosed in the December 31, 2025 Form 10-K
- No new regulatory, legal, operational, competitive, or financial risk details provided
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other NEOGENOMICS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.